The meaning of hypokalemia in heart failure

International Journal of Cardiology

Volumn 158, Issue 1, 2012, Pages 12-17

  Bielecka Dabrowa, Agata ^a   Mikhailidis, Dimitri P ^b   Jones, Linda ^c   Rysz, Jacek ^a   Aronow, Wilbert S ^d   Banach, MacIej ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Diuretics; Heart failure; Hypokalemia; Potassium

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUMETANIDE; DIGOXIN; DIURETIC AGENT; EPLERENONE; FUROSEMIDE; LOOP DIURETIC AGENT; PLACEBO; POTASSIUM ION; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TORASEMIDE;

CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; DIGITALIS INTOXICATION; DISEASE ASSOCIATION; DISEASE SEVERITY; DIURETIC THERAPY; DOSE RESPONSE; DRUG BINDING; DRUG CLEARANCE; DRUG DOSE COMPARISON; DRUG MECHANISM; DRUG MEGADOSE; DRUG MONITORING; DRUG SAFETY; DRUG WITHDRAWAL; HEART DEATH; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERKALEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPONATREMIA; LOW DRUG DOSE; OPTIMAL DRUG DOSE; PATHOPHYSIOLOGY; POTASSIUM BALANCE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK FACTOR; SUPPLEMENTATION; TREATMENT OUTCOME;

HEART FAILURE; HUMANS; HYPOKALEMIA;

EID: 80052874960     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.06.121     Document Type: Review

References (62)

1. W.B. Kannel, K. Ho, and T. Thom Changing epidemiological features of cardiac failure Br Heart J 72 1994 S3 S9 (suppl)
2. J.N. Cohn, D.G. Archibald, and S. Ziesche Effects of vasodilator therapy on mortality in chronic congestive heart failure: a result of a veterans affairs comparative study (V-HEFT) New Engl J Med 314 1986 1547 1552
3. J.N. Cohn, G. Johnson, and S. Ziesche A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure New Engl J Med 325 1991 303 310
4. F.C. Kempf, and M.E. Josephson Cardiac arrest recorded on ambulatory electrocardiograms Am J Cardiol 427 1984 241 251
5. M. Luu, W.G. Stevenson, L.W. Stevenson, K. Baron, and J. Walden Diverse mechanisms of unexpected cardiac arrest in advanced heart failure Circulation 80 1989 1675 1680
6. W.G. Stevenson, L.W. Stevenson, H.R. Middlekauff, and L.A. Saxon Sudden death prevention in patients with advanced ventricular dysfunction Circulation 88 1993 2953 2961
7. G.F. Tomaselli, and E. Marban Electrophysiological remodeling in hypertrophy and heart failure Cardiovasc Res 42 1999 270 283
8. I. Dursun, and M. Sahin Difficulties in maintaining potassium homeostasis in patients with heart failure Clin Cardiol 29 9 2006 388 392
9. J.E. Macdonald, and A.D. Struthers What is the optimal serum potassium level in cardiovascular patients? J Am Coll Cardiol 43 2004 155 161
10. G.R. Meneely, and H.D. Battarbee High sodium-low potassium environment and hypertension Am J Cardiol 38 1976 768 785
11. M. Schulman, and R.G. Narins Hypokalemia and cardiovascular disease Am J Cardiol 65 1990 4E 9E
12. A.W. Hoes, D.E. Grobbee, T.M. Peet, and J. Lubsen Do non-potassium sparing diuretics increase the risk of sudden cardiac death in hypertensive patients? Recent evidence Drugs 47 1994 711 733
13. A. Delgado-Almeida, and C. Delgado-Leon Changes in plasma ionized calcium and RBC K content in severe hyperkalemia: new electrocardiographic concept Circulation 114 suppl II 2006 II-466
14. J.E. Macdonald, and A.D. Struthers What is the optimal serum potassium level in cardiovascular patients? J Am Coll Cardiol 43 2004 155 161
15. J.N. Cohn, P.R. Kowey, P.K. Whelton, and L.M. Prisant New guidelines for potassium replacement in clinical practice. A contemporary review by the National Council on Potassium in Clinical Practice Arch Intern Med 160 2000 2429 2436
16. J.G. Cleland, H.J. Dargie, I. Robertson, J.I. Robertson, and B.W. East Total body electrolyte composition in patients with heart failure: a comparison with normal subjects and patients with untreated hypertension Br Heart J 58 1987 230 238
17. J.G. Cleland, H.J. Dargie, and B.W. East Total body and serum electrolyte composition in heart failure: the effects of captopril Eur Heart J 6 1985 681 688
18. A.B. Maron, and J.A. Leopold Aldosterone receptor antagonists. Effective but often forgotten Circulation 121 2010 934 939
19. K.T. Weber Aldosterone in congestive heart failure N Engl J Med 345 2001 1689 1697
20. J.A. Leopold, A. Dam, and B.A. Maron Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity Nat Med 13 2007 189 197
21. K.K. Gaddam, A. Verma, M. Thompson, R. Amin, and H. Ventura Hypertension and cardiac failure in its various forms Med Clin North Am 93 2009 665 680
22. G.H. Williams Aldosterone and heart failure: the rest of the story Heart Fail Rev 10 2005 5 6
23. C. Davidson, M.S. McLachlan, and L. Burkinshaw Effect of long-term diuretic treatment on body-potassium in heart-disease Lancet 2 1976 1044 1047
24. D.C. Brater Diuretic therapy N Engl J Med 339 1998 387 395
25. G.S. Francis, C. Benedict, and D.E. Johnstone Comparison of neuroendocrine activation in patients with left-ventricular dysfunction with and without congestive-heart-failure - a substudy of the Studies of Left-Ventricular Dysfunction (SOLVD) Circulation 82 1990 1724 1729
26. G.S. Francis, R.M. Siegel, S.R. Goldsmith, M.T. Olivari, T.B. Levine, and J.N. Cohn Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart-failure - activation of the neurohumoral axis Ann Intern Med 103 1985 1 6
27. J. Bayliss, M. Norell, R. Canepaanson, G. Sutton, and P. Poolewilson Untreated heart-failure - clinical and neuroendocrine effects of introducing diuretics Br Heart J 57 1987 17 22
28. L. Klein, C.M. O'Connor, and J.D. Leimberger Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure (OPTIME-CHF) study Circulation 111 2005 2454 2460
29. H.A. Cooper, D.L. Dries, C.E. Davis, Y.L. Shen, and M.J. Domanski Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction Circulation 100 1999 1311 1315
30. J.N. Cohn, P.R. Kowey, P.K. Whelton, and L.M. Prisant New guidelines for potassium replacement in clinical practice. A contemporary review by the national council on potassium in clinical practice Arch Intern Med 160 2000 2429 2436
31. C. Fisch, S.B. Knoebel, H. Feigenbaum, and K. Greenspan Potassium and the monophasic action potential, electrocardiogram, conduction and arrhythmias Prog Cardiovasc Dis 8 1966 387 418
32. L. Gettes, and B. Surawicz Effects of low and high concentrations of potassium on the simultaneously recorded Purkinje and ventricular action potentials of the perfused pig moderator band Circ Res 23 1968 717 729
33. M. Packer Sudden unexpected death in patients with congestive heart failure: a second frontier Circulation 72 1985 681 685
34. D.M. Salerno, R.W. Asinger, J. Elsperger, E. Ruiz, and M. Hodges Frequency of hypokalemia after successfully resuscitated out-of hospital cardiac arrest compared with that in transmural acute myocardial infarction Am J Cardiol 59 1987 84 88
35. H.A. Cooper, D.L. Dries, C.E. Davis, Y.L. Shen, and M.J. Domanski Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction Circulation 100 1999 1311 13315
36. M.R. Rosen, H. Gelband, C. Merker, and B.F. Hoffman Mechanisms of digitalis toxicity: effects of ouabain on phase four of canine Purkinje fiber transmembrane potentials Circulation 47 1973 681 689
37. J.E. Macdonald, and A.D. Struthers What is the optimal serum potassium level in cardiovascular patients? J Am Coll Cardiol 43 2004 155 161
38. T.N. Srivastava, and D.B. Young Impairment of cardiac function by moderate potassium depletion J Card Fail 1 1995 195 200
39. C.B. Bowling, B. Pitt, and M.I. Ahmed Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies Circ Heart Fail 3 2 2010 253 260
40. A. Ahmed, F. Zannad, and T.E. Love A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure Eur Heart J 28 2007 1334 1343
41. A.B. Alper, R.C. Campbell, and S.D. Anker A propensity-matched study of low serum potassium and mortality in older adults with chronic heart failure Int J Cardiol 11 137(1) 2009 1 8
42. Digitalis Investigation Group The effect of digoxin on mortality and morbidity in patients with heart failure N Engl J Med 336 1997 525 533
43. B. Pitt, G. Bakris, L.M. Ruilope, L. DiCarlo, and R. Mukherjee Serum potassium and clinical outcomes in the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS) Circulation 118 2008 1643 1650
44. A. Ahmed, B. Pitt, and S.H. Rahimtoola Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial Int J Cardiol 123 2008 138 146
45. J. Nolan, P.D. Batin, and R. Andrews Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart) Circulation 98 1998 1510 1516
46. C.V. Leier, L. Dei Cas, and M. Metra Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia Am Heart J 128 1994 564 574
47. M. Jessup, W.T. Abraham, and D.E. Casey 2009 Focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 1977 2016
48. A. Desai Hyperkalemia associated with inhibitors of the renin-angiotensin-aldosterone system balancing risk and benefit Circulation 118 2008 1609 1611
49. A.B. Maron, and J.A. Leopold Aldosterone receptor antagonists. Effective but often forgotten Circulation 121 2010 934 939
50. M.A. Perazella Drug-induced hyperkalemia: old culprits and new offenders Am J Med 109 2000 307 314
51. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure. The randomized aldactone evaluation study (RALES) Am J Cardiol 78 1996 902 907
52. B. Pitt, F. Zannad, and W.J. Remme The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators N Engl J Med 341 1999 709 717
53. C.S. Cruz, A.A. Cruz, and C.A. Marcilio de Souza Hyperkalaemia in congestive heart failure patients using ACE inhibitors and spironolactone Nephrol Dial Transplant 18 2003 1814 1819
54. H. Schepkens, R. Vanholder, and J.M. Billiouw Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases Am J Med 110 2001 438 441
55. M. Svensson, F. Gustafsson, and S. Galatius How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure? J Card Fail 10 2004 297 303
56. B. Pitt, G. Bakris, L.M. Ruilope, L. DiCarlo, and R. Mukherjee Serum potassium and clinical outcomes in the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS) Circulation 118 2008 1643 1650
57. European Society of Cardiology; Heart Failure Association of the ESC (HFA); European Society of Intensive Care Medicine (ESICM). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail 10 10 2008 933 989
58. B. Pitt, W. Remme, and F. Zannad Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321
59. X. Gao, L. Peng, and C.M. Adhikari Spironolactone reduced arrhythmia and maintained magnesium homeostasis in patients with congestive heart failure J Card Fail 13 2007 170 177
60. O.J. Ekundayo, C. Adamopoulos, and M.I. Ahmed Oral potassium supplement use and outcomes in chronic heart failure: a propensity-matched study Int J Cardiol 141 2010 167 174
61. A. Ahmed, Ch Adamopoulos, X. Sui, and T.E. Love Abstract 3395: potassium supplement use may increase hospitalization without affecting mortality in chronic heart failure: implications for use of aldosterone antagonists to maintain potassium balance in chronic heart failure Circulation 116 2007 II-766
62. L.G. Shewan, and A.J. Coats Ethics in the authorship and publishing of scientific articles Int J Cardiol 144 2010 1 2